In order to assist risk assessors, ARCHE Consulting and Chemycal have jointly developed an endocrine disruptor (ED) screening tool for co-formulants in biocidal products: EDScreener.

These ED assessments are mandatory for all active substances and co-formulants present in biocidal products, since the scientific criteria for determining ED properties under the BPR entered into force in 2018. The tool implements advanced data scraping technologies to automate a large part of the otherwise labour-intensive process by automatically checking existing EU programs and websites with information on ED properties of chemicals. All collected information is structured in an easily accessible table format in accordance with the approach developed by the competent authorities (CG-34-2019-02 AP 16.5 e-consultation ED potential of co-formulants_final). This can help applicants (and regulators) structuring and simplifying the tasks associated with ED assessments, in a continuously developing and challenging regulatory framework.

For more information on the EDScreener or ED assessments in general, please contact sabine.navis@arche-consulting.be or luca@chemycal.com. First experiences with the process and IT tool will also be presented at the SETAC conference in Dublin on Monday 4 May 2020.